XRF ScientificASX:XRF -1.96%100 Altman Z-Score is 14.78 as of Jun. 26, 2026, which is 168% above its 10-year median of 5.52. GuruFocus rates ASX:XRF with a GF Score™ of 100/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 544 Conglomerates companies, XRF Scientific ranks better than 97.24% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 15.09 is strong.
XRF Scientific has a Altman Z-Score of 14.78, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for XRF Scientific's Altman Z-Score or its related term are showing as below:
ASX:XRF'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.48 Med: 5.52 Max: 15.09
Current: 15.09
During the past 13 years, XRF Scientific's highest Altman Z-Score was 15.09. The lowest was 3.48. And the median was 5.52.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
XRF Scientific Altman Z-Score Related Terms
XRF Scientific Altman Z-Score Historical Data
* Premium members only.
The historical data trend for XRF Scientific's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific Altman Z-Score vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where XRF Scientific's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
XRF Scientific's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.4455
+
1.4
*
0.4428
+
3.3
*
0.204
+
0.6
*
20.2367
+
1.0
*
0.8132
=
14.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
XRF Scientific (ASX:XRF) has a Altman Z-Score of 14.78 as of Jun. 26, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on XRF Scientific and its competitors. This is 168% above median its historical median of 5.52. Over the past decade, XRF Scientific's Altman Z-Score has ranged from 3.48 to 15.09. According to the industry distribution chart, XRF Scientific ranks #15 out of 544 companies in the Conglomerates industry, placing it in the top 2.8%.
Is XRF Scientific's Altman Z-Score too high?
XRF Scientific's current Altman Z-Score of 14.78 is 168% above median its 10-year median of 5.52. Over the past 10 years, this metric has ranged from a low of 3.48 to a high of 15.09. The Conglomerates industry median Altman Z-Score is 2.07. XRF Scientific's value of 14.78 is 614% above this industry median. Based on the distribution chart, XRF Scientific ranks #15 out of 544 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Altman Z-Score compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #15 out of 544 companies for Altman Z-Score. This places XRF Scientific in the top 3% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.07. XRF Scientific's value of 14.78 is 614% above this benchmark. Historically, XRF Scientific's own Altman Z-Score has ranged from 3.48 to 15.09 over the past decade. While the company's 10-year median is 5.52 vs. the industry median of 2.07, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Conglomerates company?
The median Altman Z-Score among Conglomerates companies is 2.07, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current Altman Z-Score of 14.78 is 614% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median Altman Z-Score is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current Altman Z-Score is 14.78, which is 168% above median its own 10-year median of 5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.75 — trading 6.1% above its estimated fair value. The current Altman Z-Score is 14.78, which is 168% above median its 10-year median of 5.52 and 614% above the Conglomerates industry median of 2.07. XRF Scientific's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Altman Z-Score is 14.78 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.75 is trading 6.1% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Altman Z-Score: 14.78 (168% above median its 10-year median of 5.52)
GF Value™: A$1.65 vs. price of A$1.75 (6.1% above fair value)
Industry Position: 614% above the Conglomerates median (#15 of 544)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
100GF Score
Get the complete analysis for ASX:XRF
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
